RhumbLine Advisers’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$968K Buy
25,700
+549
+2% +$17.9K ﹤0.01% 2209
2025
Q4
$757K Buy
25,151
+4,056
+19% +$115K ﹤0.01% 2384
2025
Q3
$553K Buy
21,095
+4,921
+30% +$117K ﹤0.01% 2629
2025
Q2
$345K Buy
16,174
+8,860
+121% +$200K ﹤0.01% 2908
2025
Q1
$155K Sell
7,314
-55
-0.7% -$1.13K ﹤0.01% 3228
2024
Q4
$149K Buy
+7,369
New +$152K ﹤0.01% 3338

Other funds holding GRDN

RhumbLine Advisers's GRDN Position: Q1 2026 in Review

RhumbLine Advisers increased its Guardian Pharmacy Services (GRDN) stake by 2.2% in Q1 2026, buying an estimated $17.9K and bringing the position to 25,700 shares worth $968K. The position accounts for ﹤0.01% of the portfolio, ranked #2209.

RhumbLine Advisers first reported a position in GRDN in Q4 2024 and has held it in 6 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • RhumbLine Advisers held 25,700 shares of Guardian Pharmacy Services worth $968K as of Q1 2026.
  • RhumbLine Advisers bought 549 Guardian Pharmacy Services shares in Q1 2026, an estimated $17.9K.
  • Guardian Pharmacy Services made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2209 holding.
  • RhumbLine Advisers first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 6 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.